Evidence map›Paper›PMID 35409029›Full record

ReviewInternational journal of molecular sciences2022

Gases in Sepsis: Novel Mediators and Therapeutic Targets.

Zhixing Zhu, Stephen Chambers, Yiming Zeng, Madhav Bhatia

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Muramyl dipeptide potentiatesFrontiers in immunology · 2024
    Article
  11. Review
  12. Review
  13. Inflammation and Organ Injury the Role of Substance P and Its Receptors.International journal of molecular sciences · 2023
    Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Zhixing ZhuDepartment of Pathology and Biomedical Science, University of Otago, Christchurch 8140, New Zealand.ORCID 0000-0002-5991-3264
Stephen ChambersDepartment of Pathology and Biomedical Science, University of Otago, Christchurch 8140, New Zealand.
Yiming ZengDepartment of Internal Medicine (Pulmonary and Critical Care Medicine), The Second Clinical Medical School of Fujian Medical University, Quanzhou 362002, China.
Madhav BhatiaDepartment of Pathology and Biomedical Science, University of Otago, Christchurch 8140, New Zealand.
Fujian Medical University · CNUniversity of Otago · NZ

Funding

Maurice and Phyllis Paykel TrustUniversity of Otago Vice-Chancellor's Strategic Development Fund
6 · The paper itself

Abstract

Sepsis, a potentially lethal condition resulting from failure to control the initial infection, is associated with a dysregulated host defense response to pathogens and their toxins. Sepsis remains a leading cause of morbidity, mortality and disability worldwide. The pathophysiology of sepsis is very complicated and is not yet fully understood. Worse still, the development of effective therapeutic agents is still an unmet need and a great challenge. Gases, including nitric oxide (NO), carbon monoxide (CO) and hydrogen sulfide (H

Indexed as

GasotransmittersHydrogen SulfideSepsisCarbon MonoxideGasesHumansNitric OxideCarbon MonoxideGasesGasotransmittersHydrogen SulfideNitric OxideCOgaseous mediatorsH2SNOpathophysiologysepsistherapeutic targets

Identifiers

PMID35409029
PMCPMC8998565
OpenAlexW4220743150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.